RUN vs TERN
Sunrun Inc (RUN) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the RUN and TERN stock pages for the full models.
Not investment advice.